Sébastien Sauvage

1.9k total citations
20 papers, 1.5k citations indexed

About

Sébastien Sauvage is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sébastien Sauvage has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Sébastien Sauvage's work include Muscle Physiology and Disorders (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA Research and Splicing (3 papers). Sébastien Sauvage is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA Research and Splicing (3 papers). Sébastien Sauvage collaborates with scholars based in Belgium, United States and France. Sébastien Sauvage's co-authors include Róbert Kiss, Eugénie Ansseau, Denise A. Figlewicz, Frédérique Coppée, Dalila Laoudj‐Chenivesse, Alexandra Belayew, Florence Lefranc, Christine Decaestecker, Oberdan Léo and Christel Mattéotti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Sébastien Sauvage

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Sauvage Belgium 15 1.0k 247 226 171 166 20 1.5k
K. Kishta Reddy United States 17 1.1k 1.0× 211 0.9× 94 0.4× 104 0.6× 147 0.9× 23 1.8k
Shin‐ichi Tsukamoto Japan 22 765 0.7× 652 2.6× 139 0.6× 147 0.9× 117 0.7× 71 1.6k
Allan S. Wagman United States 17 1.4k 1.3× 447 1.8× 73 0.3× 285 1.7× 196 1.2× 28 2.2k
Kenneth J. Shaw United States 15 619 0.6× 315 1.3× 67 0.3× 476 2.8× 232 1.4× 26 1.4k
Christopher H. Hill United Kingdom 14 960 0.9× 353 1.4× 49 0.2× 152 0.9× 151 0.9× 22 1.5k
Urs Regenass Switzerland 23 860 0.8× 194 0.8× 75 0.3× 315 1.8× 81 0.5× 43 1.3k
Wooyoung Hur United States 19 1.3k 1.3× 402 1.6× 161 0.7× 253 1.5× 100 0.6× 35 1.9k
Hao Jia China 18 377 0.4× 418 1.7× 233 1.0× 102 0.6× 78 0.5× 59 1.3k
Anthony E. Boitano United States 15 1.1k 1.1× 93 0.4× 404 1.8× 374 2.2× 496 3.0× 61 2.3k
Valérie Gouazé‐Andersson France 20 1.3k 1.2× 82 0.3× 73 0.3× 277 1.6× 154 0.9× 31 1.6k

Countries citing papers authored by Sébastien Sauvage

Since Specialization
Citations

This map shows the geographic impact of Sébastien Sauvage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Sauvage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Sauvage more than expected).

Fields of papers citing papers by Sébastien Sauvage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Sauvage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Sauvage. The network helps show where Sébastien Sauvage may publish in the future.

Co-authorship network of co-authors of Sébastien Sauvage

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Sauvage. A scholar is included among the top collaborators of Sébastien Sauvage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Sauvage. Sébastien Sauvage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petit, B., et al.. (2020). c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis. Targeted Oncology. 15(1). 139–146. 7 indexed citations
2.
Trafalis, Dimitrios T., et al.. (2018). Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma. Journal of Immunotherapy. 41(6). 300–305. 30 indexed citations
3.
Iranzo, Vega, et al.. (2018). Clinical impact of using a deep genomic profile in carcinoma of unknown origin. Annals of Oncology. 29. vi10–vi10. 1 indexed citations
4.
Laes, Jean‐François, et al.. (2017). Tumor-biopsy stratification based on mTOR-pathway activity and functional mutations in the upstream genes PIK3CA and PTEN. Oncotarget. 8(48). 84426–84433. 4 indexed citations
5.
Burtéa, Carmen, Sophie Laurent, Sébastien Sauvage, et al.. (2016). Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium. Arthritis Research & Therapy. 18(1). 230–230. 11 indexed citations
6.
Maris, Calliope, Nicky D’Haene, Marie Le Mercier, et al.. (2015). IGF-IR: a new prognostic biomarker for human glioblastoma. British Journal of Cancer. 113(5). 729–737. 56 indexed citations
7.
Trépant, Anne‐Laure, Christelle Bouchart, Sandrine Rorive, et al.. (2014). Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. Tumor Biology. 36(3). 1943–1953. 36 indexed citations
8.
Bondue, Benjamin, Félicie Sherer, Gaëtan Van Simaeys, et al.. (2014). PET/CT with 18F-FDG– and 18F-FBEM–Labeled Leukocytes for Metabolic Activity and Leukocyte Recruitment Monitoring in a Mouse Model of Pulmonary Fibrosis. Journal of Nuclear Medicine. 56(1). 127–132. 37 indexed citations
9.
D’Haene, Nicky, Sébastien Sauvage, Calliope Maris, et al.. (2013). VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis. PLoS ONE. 8(6). e67029–e67029. 97 indexed citations
10.
Rorive, Sandrine, Xavier Moles Lopez, Calliope Maris, et al.. (2010). TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Modern Pathology. 23(10). 1418–1428. 37 indexed citations
11.
Ansseau, Eugénie, Dalila Laoudj‐Chenivesse, Alexandra Tassin, et al.. (2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE. 4(10). e7482–e7482. 54 indexed citations
12.
Lefranc, Florence, Sébastien Sauvage, Gwendoline Van Goietsenoven, et al.. (2009). Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Molecular Cancer Therapeutics. 8(7). 1739–1750. 86 indexed citations
13.
Ingrassia, Laurent, Florence Lefranc, Janique Dewelle, et al.. (2009). Structure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer Agents. Journal of Medicinal Chemistry. 52(4). 1100–1114. 130 indexed citations
14.
Lefranc, Florence, Tatjana Mijatovic, Yasuko Kondo, et al.. (2008). TARGETING THE α 1 SUBUNIT OF THE SODIUM PUMP TO COMBAT GLIOBLASTOMA CELLS. Neurosurgery. 62(1). 211–222. 140 indexed citations
15.
Gnoula, Charlemagne, Véronique Mégalizzi, Nancy De Nève, et al.. (2008). Balanitin-6 and -7: Diosgenyl saponins isolated from Balanites aegyptiaca Del. display significant anti-tumor activity in vitro and in vivo. International Journal of Oncology. 61 indexed citations
16.
Ansseau, Eugénie, Cecı́lia Conde, Sébastien Sauvage, et al.. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular Disorders. 17(8). 611–623. 258 indexed citations
17.
Quaquebeke, Eric Van, Patrick Dumont, Janique Dewelle, et al.. (2007). 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a Novel Nonhematotoxic Naphthalimide Derivative with Potent Antitumor Activity. Journal of Medicinal Chemistry. 50(17). 4122–4134. 121 indexed citations
18.
Dixit, Manjusha, Eugénie Ansseau, Alexandra Tassin, et al.. (2007). DUX4 , a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences. 104(46). 18157–18162. 285 indexed citations
19.
Mathieu, Véronique, Marie Le Mercier, Nancy De Nève, et al.. (2007). Galectin-1 Knockdown Increases Sensitivity to Temozolomide in a B16F10 Mouse Metastatic Melanoma Model. Journal of Investigative Dermatology. 127(10). 2399–2410. 83 indexed citations
20.
Ansseau, Eugénie, Dalila Laoudj‐Chenivesse, Sébastien Sauvage, et al.. (2006). G.P.9 06 Characterization of the DUX4c gene located within a repeated element close to the FSHD locus. Neuromuscular Disorders. 16(9-10). 712–712. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Kishta Reddy Breakdown of academic impact, for papers by Shin‐ichi Tsukamoto Breakdown of academic impact, for papers by Allan S. Wagman Breakdown of academic impact, for papers by Kenneth J. Shaw Breakdown of academic impact, for papers by Christopher H. Hill Breakdown of academic impact, for papers by Urs Regenass Breakdown of academic impact, for papers by Wooyoung Hur Breakdown of academic impact, for papers by Hao Jia Breakdown of academic impact, for papers by Anthony E. Boitano Breakdown of academic impact, for papers by Valérie Gouazé‐Andersson
Rankless by CCL
2026